Literature DB >> 26206996

The role of interstitial changes in the progression of chronic kidney disease.

Beata Sulikowska1, Bolesław Rutkowski2, Andrzej Marszałek3, Jacek Manitius1.   

Abstract

Interstitium - the renal tubulointerstitial compartment - is located between the renal tubule basement membrane and microcirculation vessels. Interstitial fibroblasts produce the extracellular matrix and constitute the structure's cellular skeleton, regulating spatial relationships between its components (microenvironment). The tubular epithelium and endothelium cooperate within an integrated microenvironment. Structural or functional impairment of the extracellular matrix, microcirculation vessels or tubular epithelium results in disturbances of tubulointerstitial compartment components. In the course of glomerular kidney diseases, the intrarenal RAA system becomes activated and inflammatory mediators are released. Interstitial inflammation and microcirculatory disorders develop, inducing adverse consequences, manifested mainly through the process of hypoxia and inflammation. Inflammation-induced increase in interleukin-1 (TNF-α) expression leads to increased concentrations of VEGF, ICAM-1, angiotensin II, IL-6 and IL-8. Cytokines activate fibroblasts, myofibroblasts and endothelial cells. Fibrosis is also triggered by HIF-1alpha pathway activation, resulting in vascular growth and fibroblast proliferation. This reaction likewise occurs through activation of NF-ĸβ, EPO, GLUT-1, IGF-1 and INOS. Interstitial fibrosis is one of the factors determining the clinical course of kidney diseases. Apart from inducing fibrosis, microcirculatory disorders lead to the progression of hypoxia. Angiogenesis is a part of the repair process accompanying fibrosis. Its determinant is the normal function and structure of endothelial cells manifested by their ability to migrate and proliferate in response to, inter alia, angiopoietins, VEGF and nitric oxide synthase. Administering a three-drug RAAS-inhibiting therapy to patients with chronic glomerulopathies improves tubular function, measured by the decrease in excretion of NAG and propeptide of type III procollagen fibres, and contributes to the improvement in microcirculation functioning.

Entities:  

Mesh:

Year:  2015        PMID: 26206996     DOI: 10.5604/17322693.1162570

Source DB:  PubMed          Journal:  Postepy Hig Med Dosw (Online)        ISSN: 0032-5449            Impact factor:   0.270


  5 in total

1.  Transplantation of Amniotic Fluid-Derived Stem Cells Preconditioned with Glial Cell Line-Derived Neurotrophic Factor Gene Alleviates Renal Fibrosis.

Authors:  Shulin Li; Yuan Zhao; Zhuojun Wang; Jia Wang; Caixia Liu; Dong Sun
Journal:  Cell Transplant       Date:  2018-11-30       Impact factor: 4.064

2.  Enhanced renoprotective effect of GDNF-modified adipose-derived mesenchymal stem cells on renal interstitial fibrosis.

Authors:  Shulin Li; Yanping Wang; Zhuojun Wang; Lu Chen; Bangjie Zuo; Caixia Liu; Dong Sun
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

3.  Normotensive and hypertensive Immunoglobulin a nephropathy with ischemic renal injury: clinicopathological characteristics and prognosis.

Authors:  Yongli Wang; Xutong Wang; Dan Yu; Minhua Xie; Jingjing Ren; Yuze Zhu; Haonan Guo; Songxia Quan; Junjun Zhang
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

4.  A Sedentary and Unhealthy Lifestyle Fuels Chronic Disease Progression by Changing Interstitial Cell Behaviour: A Network Analysis.

Authors:  Patricia Huston
Journal:  Front Physiol       Date:  2022-07-08       Impact factor: 4.755

5.  Association between Helicobacter pylori infection and kidney damage in patients with peptic ulcer.

Authors:  Wei Pan; Hui Zhang; Li Wang; Tingting Zhu; Bo Chen; Junming Fan
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.